Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda

BACKGROUND: Little is known about the incidence of virological failure among Human Immunodeficiency virus (HIV) infected adults after Uganda transitioned from Zidovidine/Lamivudine/ Nevirapine (AZT/3TC/NVP) to Tenofovir/Lamivudine/Efavirenze (TDF/3 T/EFV) as a first-line anti-retroviral therapy (ART...

Descripción completa

Detalles Bibliográficos
Autores principales: Izudi, Jonathan, Alioni, Sunday, Kerukadho, Emmanuel, Ndungutse, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084428/
https://www.ncbi.nlm.nih.gov/pubmed/27793124
http://dx.doi.org/10.1186/s12879-016-1952-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084428/
https://www.ncbi.nlm.nih.gov/pubmed/27793124
http://dx.doi.org/10.1186/s12879-016-1952-x

Ejemplares similares